Skip to main content
. 2020 Nov 3;7(12):ofaa537. doi: 10.1093/ofid/ofaa537

Table 2.

Bivariate Analysis of Hospitalized Patients Presenting to the Emergency Department Ultimately Diagnosed With Asymptomatic Bacteriuria and Treated With Antibiotics by Emergency Medicine Clinicians Versus Never Treated With Antibiotics, N = 1884

Variable Antibiotic Treatment by EM (n = 1253) No Antibiotics (n = 631) Odds Ratio (95% CI) P Valuea
Baseline Characteristics
Age (median, IQR) 80 (69–87) 75 (62–85) 1.02 (1.01–1.03) <.0001
Gender (female) 911 (72.7%) 471 (74.6%) 0.99 (0.78–1.25) .92
Race (white) 921 (74.0%) 495 (78.6%) 0.95 (0.79–1.13) .54
Charlson comorbidity index,0 132 (10.5%) 84 (13.3%) REF .16
1–2 407 (32.5%) 200 (31.7%) 1.28 (0.91–1.79)
3–4 396 (31.6%) 175 (27.7%) 1.42 (1.04–1.94)
≥5 318 (25.4%) 172 (27.3%) 1.27 (0.96–1.67)
Diabetes 452 (36.1%) 250 (39.6%) 0.89 (0.73–1.10) .29
Moderate or severe chronic kidney disease 520 (41.5%) 247 (39.1%) 1.24 (0.96–1.61) .10
History of cancer 261 (20.8%) 132 (20.9%) 1.04 (0.85–1.28) .68
Spinal cord injury 35 (02.8%) 3 (0.5%) 5.17 (1.42–18.77) .01
Dementia 384 (30.6%) 87 (13.8%) 2.27 (1.83–2.83) <.0001
Immunosuppressedb 37 (03.0%) 18 (2.9%) 1.24 (0.61–2.52) .55
IV chemotherapy in preceding 30 days 10 (00.8%) 6 (1.0%) 0.96 (0.20–4.58) .96
Hemodialysis 20 (01.6%) 9 (1.4%) 0.84 (0.51–1.37) .48
Transfer from postacute carec 88 (07.0%) 27 (4.3%) 1.74 (1.27–2.39) .0006
Nonambulatory 224 (17.9%) 55 (8.7%) 1.92 (1.46–2.53) <.0001
Hospitalization in past 90 days 373 (29.8%) 195 (30.9%) 0.92 (0.76–1.10) .34
Antibiotics in preceding 90 days 263 (21.0%) 92 (14.6%) 1.31 (1.06–1.62) .011
Indwelling catheter 215 (17.2%) 58 (9.2%) 1.55 (1.21–1.98) .0006
Any urinary catheterd 249 (19.9%) 68 (10.8%) 1.55 (1.22–1.96) .0003
Signs and Symptoms
Abdominal pain 248 (19.8%) 158 (25.0%) 0.88 (0.73–1.05) .16
Incontinence 445 (35.5%) 138 (21.9%) 2.20 (1.80–2.68) <.0001
Functional decline 93 (07.4%) 28 (04.4%) 1.79 (0.88–3.64) .11
Acutely altered mental status 393 (31.4%) 86 (13.6%) 2.51 (2.02–3.13) <.0001
Fatigue, malaise, lethargy 396 (31.6%) 175 (27.7%) 1.53 (1.16–2.01) .003
Nausea or vomiting 267 (21.3%) 179 (28.4%) 0.88 (0.69–1.13) .33
Change in color, sediment, or malodorous urine 202 (16.1%) 71 (11.3%) 1.93 (1.23–3.03) .004
Urinary retention or postvoid residual > 200 cc 143 (11.4%) 54 (08.6%) 1.34 (0.96–1.88) .08
Severity of Illness
qSOFAe (≥2 vs <2) 152 (12.1%) 65 (10.3%) 1.33 (1.06–1.68) .01
≥ 2 SIRSf criteria 300 (23.9%) 191 (30.3%) 0.80 (0.66–0.97) .02
Laboratory Results
Peripheral leukocytosisg 356 (28.4%) 186 (29.5%) 1.01 (0.87–1.16) .93
Abnormal urinalysish 1232 (98.3%) 528 (83.7%) 9.42 (5.30–16.75) <.0001
Hospital Characteristics
Type of control
 Not-for-profit 1141 (91.1%) 606 (96.0%) REF .04
 For profit 112 (8.9%) 25 (4.0%) 2.57 (1.03–6.40)
Bed size (10 bed increase) 327 (203–443) 310 (189–443) 1.01 (0.99–1.01) .62
Teaching hospital 1165 (93.0%) 555 (88.0%) 1.19 (0.59–2.40) .62

Abbreviations: CI, confidence interval; EM, emergency medicine clinician; IQR, interquartile range; IV, intravenous; qSOFA, quick sequential organ failure assessment; REF, Reference; SIRS, systemic inflammatory response syndrome.

a P < .05 is considered significant.

bDefined as chemotherapy administered within 30 days, human immunodeficiency virus with CD4 >200, ≥10 mg/day prednisone for at least 30 days (or equivalent steroid dose), on biologic agents such as tumor necrosis factor inhibitors or other immunosuppressant agents, congenital or acquired immunodeficiency.

cIncludes transfer from the following: subacute rehabilitation center, skilled nursing home, acute rehabilitation center, assisted living, other hospital. Also includes if patient had been admitted or resided in a nursing home, subacute rehabilitation center, or extended care facility in the prior 30 days.

dIncludes Foley catheter, intermittent straight catheterization, and suprapubic catheter present on day of urine culture collection or 1 day before urine culture collection.

eQuick SOFA score: systolic blood pressure ≤100 mmHg = 1, respiratory rate ≥22 breaths per minute = 1; Glasgow coma score <15 = 1.

fSIRS (temperature <36°C [96.8°F] or > 38.0°C [100.4°F], heart rate >90 beats per minute, respiratory rate >20 breaths per minute, white blood cell count <4000/mm3 or >12 000/mm3).

gDefined as white blood cell count >10 per high-power field.

hDefined as presence of leukocyte esterase or nitrite, or white blood cells >5 per high-power field.